Mark Driver, MD
Otolaryngology · Middletown
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 26 years
- Wright State University Boonshoft School of Medicine, 2000
Offices
2 locations · Ent and Allergy Associates LLP · 431 clinicians in this group
Hospitals listed: Garnet Health Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Driver’s office to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Garnet Health Medical CenterMiddletown, NYAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Garnet Health, which runs 3 hospitalsPatients rate it 3 of 5 · 64% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Pressure ulcer rate: 0.08 (0 to 0.56) · 11,610 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.411, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.33, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.674, Oct 2024 – Sep 2025
See every measure and the patient survey for Garnet Health Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 0.08 (0 to 0.56) · 11,610 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.411 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.33 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.674 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.7 (0 to 1.6) · 2,035 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.53 to 1.09) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 195.94 (140.45 to 251.44) · 62 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 52 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 455 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 397 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 956 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.3 · 1,055 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.7 · 463 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 5,016 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.06 to 0.42) · 12,631 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.12 to 0.47) · 12,844 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.83 (1.96 to 5.7) · 2,100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0 to 2.87) · 571 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.5 (1.13 to 3.87) · 2,067 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.83 (2.29 to 15.38) · 564 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.81 (1.25 to 8.38) · 551 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.52 (0.1 to 2.94) · 387 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 81 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.965 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.048 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 403 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 1,223 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 2.7 · 356 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 40.8 · 1,079 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 1,110 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 1,253 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.8 (3.1 to 7.1) · 105 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.4 (7.5 to 14.2) · 105 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.3 · 85 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 570 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.2 (9.4 to 15.8) · 1,104 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 830 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,214 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 79% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 64% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$143,280
Medicare paid this office $143,280 for 598 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Diagnostic exam of nasal passages using an endoscope | 247 | $45,875 | $159 |
| Short return visit (20+ min) | 382 | $43,153 | $77 |
| New patient visit (30+ min) | 142 | $13,684 | $96 |
| Diagnostic exam of voice box using a flexible endoscope | 68 | $9,107 | $111 |
| Removal of impacted ear wax | 178 | $8,650 | $34 |
See all 10 services
| Diagnostic exam of nasal passages using an endoscope | 247 | $45,875 | $159 |
| Short return visit (20+ min) | 382 | $43,153 | $77 |
| New patient visit (30+ min) | 142 | $13,684 | $96 |
| Diagnostic exam of voice box using a flexible endoscope | 68 | $9,107 | $111 |
| Removal of impacted ear wax | 178 | $8,650 | $34 |
| Return visit (30+ min) | 66 | $8,549 | $111 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 83 | $3,108 | $37 |
| New patient visit (15+ min) | 39 | $2,402 | $62 |
| Short return visit | 43 | $1,834 | $39 |
| Exam of ear using a microscope | 35 | $1,042 | $25 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Diagnostic exam of nasal passages using an endoscope | 226 | 215 | 217 | 285 | 287 | 289 |
| Removal of impacted ear wax | 236 | 218 | 261 | 257 | 250 | 251 |
| Diagnostic exam of voice box using a flexible endoscope | 120 | 95 | 104 | 111 | 107 | 82 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
598 Original Medicare patients in 2024. Average age 75 · Under 65 4% · 85 and older 14% · Women 57% · Also on Medicaid 7% · Health risk score 1.11. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 73% · Coronary heart disease 34% · Diabetes 30% · Chronic kidney disease 20% · COPD 19% · Atrial fibrillation 16% · Cancer 15% · Depression 14% · Heart failure 11% · Stroke 7% · Dementia 4%.
The office billed $545,322, Medicare allowed $190,451 and paid $143,280; for 1,662 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 598 | 1,662 | 75 | 1.11 | $545,322 | $143,280 |
| 2023 | 606 | 1,709 | 74 | 1.08 | $557,433 | $141,139 |
| 2022 | 546 | 1,719 | 74 | 1.07 | $542,502 | $145,185 |
| 2021 | 532 | 1,630 | 74 | 1.14 | $466,656 | $136,993 |
| 2020 | 471 | 1,481 | 74 | 1.17 | $349,037 | $111,615 |
| 2019 | 585 | 1,715 | 74 | 1.25 | $408,234 | $130,275 |
| 2018 | 580 | 1,711 | 73 | 1.16 | $390,053 | $128,555 |
| 2017 | 469 | 1,474 | 73 | 1.29 | $332,973 | $110,021 |
| 2016 | 521 | 1,653 | 73 | 1.31 | $392,327 | $130,929 |
| 2015 | 469 | 1,474 | 71 | 1.22 | $357,191 | $118,664 |
| 2014 | 421 | 1,438 | 71 | 1.18 | $384,739 | $108,642 |
| 2013 | 419 | 2,370 | 71 | 1.20 | $455,642 | $121,347 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Diagnostic exam of nasal passages using an endoscope | 234 | $43,859 | $153 |
| Short return visit (20+ min) | 380 | $41,215 | $74 |
| New patient visit (30+ min) | 135 | $12,154 | $90 |
| Diagnostic exam of voice box using a flexible endoscope | 87 | $11,035 | $103 |
| Return visit (30+ min) | 78 | $9,050 | $108 |
| Removal of impacted ear wax | 184 | $8,247 | $33 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 82 | $3,282 | $40 |
| Short return visit | 60 | $2,788 | $41 |
| New patient visit (45+ min) | 13 | $1,895 | $146 |
| New patient visit (15+ min) | 31 | $1,643 | $53 |
| Exam of ear using a microscope | 33 | $1,191 | $25 |
2022: 11 services
| Diagnostic exam of nasal passages using an endoscope | 218 | $47,620 | $167 |
| Short return visit (20+ min) | 343 | $42,407 | $74 |
| Diagnostic exam of voice box using a flexible endoscope | 88 | $11,700 | $105 |
| New patient visit (30+ min) | 123 | $11,208 | $91 |
| Removal of impacted ear wax | 192 | $8,887 | $35 |
| Return visit (30+ min) | 65 | $8,257 | $107 |
| Short return visit | 80 | $4,506 | $46 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 45 | $1,774 | $39 |
| New patient visit (15+ min) | 31 | $1,762 | $57 |
| Exam of the nose and throat using an endoscope | 13 | $1,512 | $108 |
| Exam of ear using a microscope | 34 | $1,343 | $24 |
2021: 11 services
| Short return visit (20+ min) | 330 | $41,424 | $75 |
| Diagnostic exam of nasal passages using an endoscope | 159 | $38,470 | $177 |
| New patient visit (30+ min) | 134 | $12,268 | $92 |
| Diagnostic exam of voice box using a flexible endoscope | 91 | $11,864 | $114 |
| Removal of impacted ear wax | 180 | $9,354 | $36 |
| Short return visit | 91 | $5,170 | $45 |
| Return visit (30+ min) | 34 | $4,344 | $106 |
| New patient visit (15+ min) | 42 | $2,326 | $55 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 41 | $1,729 | $42 |
| Exam of the nose and throat using an endoscope | 13 | $1,638 | $96 |
| Exam of ear using a microscope | 33 | $1,251 | $24 |
2020: 10 services
| Diagnostic exam of nasal passages using an endoscope | 150 | $35,355 | $164 |
| Short return visit (20+ min) | 296 | $30,767 | $60 |
| Diagnostic exam of voice box using a flexible endoscope | 81 | $9,789 | $103 |
| New patient visit (30+ min) | 112 | $8,180 | $73 |
| Removal of impacted ear wax | 155 | $7,346 | $34 |
| Return visit (30+ min) | 56 | $5,984 | $83 |
| Short return visit | 84 | $3,933 | $37 |
| Exam of ear using a microscope | 25 | $1,162 | $23 |
| New patient visit (15+ min) | 22 | $1,075 | $49 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 26 | $1,044 | $40 |
2019: 11 services
| Short return visit (20+ min) | 374 | $38,988 | $60 |
| Diagnostic exam of nasal passages using an endoscope | 165 | $38,508 | $170 |
| New patient visit (30+ min) | 143 | $12,144 | $85 |
| Diagnostic exam of voice box using a flexible endoscope | 97 | $11,777 | $98 |
| Removal of impacted ear wax | 185 | $8,398 | $36 |
| Return visit (30+ min) | 48 | $4,639 | $86 |
| New patient visit (15+ min) | 52 | $2,789 | $54 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 66 | $2,406 | $35 |
| Short return visit | 54 | $1,927 | $34 |
| Exam of the nose and throat using an endoscope | 16 | $1,580 | $93 |
| Exam of ear using a microscope | 23 | $735 | $24 |
2018: 11 services
| Diagnostic exam of nasal passages using an endoscope | 185 | $43,038 | $172 |
| Short return visit (20+ min) | 368 | $34,962 | $57 |
| New patient visit (30+ min) | 131 | $11,269 | $86 |
| Diagnostic exam of voice box using a flexible endoscope | 92 | $11,093 | $89 |
| Removal of impacted ear wax | 190 | $8,717 | $34 |
| New patient visit (15+ min) | 79 | $4,636 | $59 |
| Return visit (30+ min) | 36 | $3,754 | $83 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 61 | $2,441 | $39 |
| Short return visit | 47 | $1,636 | $33 |
| Exam of ear using a microscope | 30 | $1,119 | $25 |
| Exam of the nose and throat using an endoscope | 11 | $927 | $84 |
2017: 10 services
| Diagnostic exam of nasal passages using an endoscope | 158 | $41,544 | $168 |
| Short return visit (20+ min) | 288 | $26,940 | $55 |
| New patient visit (30+ min) | 116 | $8,913 | $77 |
| Diagnostic exam of voice box using a flexible endoscope | 66 | $8,164 | $92 |
| Removal of impacted ear wax | 152 | $6,989 | $32 |
| Return visit (30+ min) | 33 | $3,257 | $79 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 56 | $2,181 | $39 |
| Short return visit | 52 | $1,846 | $30 |
| New patient visit (15+ min) | 30 | $1,562 | $52 |
| Exam of ear using a microscope | 28 | $1,492 | $24 |
2016: 10 services
| Diagnostic exam of nasal passages using an endoscope | 187 | $53,393 | $175 |
| Short return visit (20+ min) | 280 | $26,637 | $55 |
| New patient visit (30+ min) | 121 | $9,978 | $82 |
| Removal of impacted ear wax | 196 | $8,786 | $33 |
| Diagnostic exam of voice box using a flexible endoscope | 64 | $7,688 | $93 |
| Return visit (30+ min) | 54 | $5,192 | $87 |
| Short return visit | 82 | $3,432 | $34 |
| New patient visit (15+ min) | 52 | $2,878 | $55 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 31 | $1,306 | $40 |
| Exam of ear using a microscope | 30 | $1,271 | $24 |
2015: 10 services
| Diagnostic exam of nasal passages using an endoscope | 170 | $44,883 | $173 |
| Short return visit (20+ min) | 280 | $27,074 | $56 |
| New patient visit (30+ min) | 116 | $9,659 | $83 |
| Diagnostic exam of voice box using a flexible endoscope | 70 | $7,764 | $94 |
| Removal of impacted ear wax | 157 | $7,116 | $33 |
| New patient visit (15+ min) | 60 | $3,511 | $59 |
| Return visit (30+ min) | 35 | $3,084 | $83 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 50 | $2,089 | $42 |
| Short return visit | 38 | $1,286 | $31 |
| Exam of ear using a microscope | 39 | $1,205 | $23 |
2014: 13 services
| Diagnostic exam of nasal passages using an endoscope | 121 | $32,076 | $173 |
| Short return visit (20+ min) | 222 | $22,572 | $58 |
| Diagnostic exam of voice box using a flexible endoscope | 99 | $13,910 | $91 |
| Removal of impacted ear wax | 133 | $6,154 | $35 |
| New patient visit (30+ min) | 64 | $5,529 | $86 |
| New patient visit (15+ min) | 70 | $3,854 | $55 |
| Short return visit | 73 | $2,728 | $32 |
| Return visit (30+ min) | 31 | $2,610 | $84 |
| Simple control of nose bleed | 13 | $1,281 | $75 |
| Exam of ear using a microscope | 27 | $1,032 | $24 |
| Professional service for multiple injections of allergen | 30 | $956 | $9 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 23 | $949 | $41 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $171 | $12 |
2013: 13 services
| Short return visit (20+ min) | 317 | $34,901 | $56 |
| Diagnostic exam of nasal passages using an endoscope | 95 | $24,643 | $172 |
| Diagnostic exam of voice box using a flexible endoscope | 111 | $18,900 | $91 |
| Removal of impacted ear wax | 147 | $7,566 | $39 |
| New patient visit (30+ min) | 90 | $7,413 | $82 |
| Return visit (30+ min) | 48 | $4,499 | $85 |
| Professional service for preparation and provision of 1 or more antigens | 16 | $2,943 | $10 |
| Professional service for multiple injections of allergen | 25 | $1,423 | $9 |
| Simple control of nose bleed | 17 | $1,400 | $74 |
| New patient visit (15+ min) | 16 | $974 | $61 |
| Professional service for single injection of allergen | 11 | $840 | $7 |
| Short return visit | 13 | $509 | $34 |
| Comprehensive hearing and speech recognition test | 11 | $280 | $25 |
Medicaid work
$2,638 in 2024
Medicaid paid $2,638 for 12 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 12 | $2,638 |
| 2024 | 12 | 1 | 12 | $2,638 |
| 2023 | 268 | 3 | 19 | $34,343 |
| 2022 | 186 | 4 | 16 | $20,477 |
| 2021 | 177 | 3 | 17 | $16,310 |
| 2020 | 139 | 2 | 20 | $7,090 |
| 2019 | 89 | 1 | 19 | $7,263 |
| 2018 | 103 | 2 | 22 | $9,573 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 138 | $13,576 |
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 50 | $11,184 |
| New patient visit (30+ min) | 80 | $9,582 |
2022
| New patient visit (30+ min) | 78 | $9,720 |
| Short return visit (20+ min) | 84 | $8,085 |
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 12 | $2,027 |
| Removal of impacted ear wax | 12 | $646 |
2021
| Short return visit (20+ min) | 119 | $11,267 |
| New patient visit (30+ min) | 42 | $5,044 |
| Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Public Health Emergency, as defined by law, due to respiratory-transmitted infectious disease | 16 | $0 |
2020
| Short return visit (20+ min) | 84 | $7,090 |
| Supplies and materials (except spectacles), provided by the physician or other qualified health care professional over and above those usually included with the office visit or other services rendered (list drugs, trays, supplies, or materials provided) | 55 | $0 |
2019
| Short return visit (20+ min) | 89 | $7,263 |
2018
| Short return visit (20+ min) | 89 | $6,627 |
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 14 | $2,947 |
Drugs they prescribed that Part D paid
$8,772
Pharmacies billed $8,772 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
432 generic and 15 brand-name prescriptions · $8,772 in drug cost · 45 antibiotic prescriptions to 37 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ofloxacin | 48 | $2,248 | $47 |
| Famotidine | 53 | $694 | $13 |
| Fluticasone Propionate | 61 | $668 | $11 |
| Acetic Acid | 20 | $602 | $30 |
| Ipratropium | 13 | $571 | $44 |
See all 13 drugs
| Ofloxacin | 48 | $2,248 | $47 |
| Famotidine | 53 | $694 | $13 |
| Fluticasone Propionate | 61 | $668 | $11 |
| Acetic Acid | 20 | $602 | $30 |
| Ipratropium | 13 | $571 | $44 |
| Betamethasone Valerate | 14 | $485 | $35 |
| Omeprazole | 56 | $420 | $8 |
| Azelastine | 23 | $397 | $17 |
| Pantoprazole | 20 | $370 | $19 |
| Levocetirizine Dihydrochloride | 26 | $239 | $9 |
| Amoxicillin-Clavulanate Potass | 31 | $218 | $7 |
| Mupirocin | 19 | $142 | $7 |
| Doxycycline Hyclate | 11 | $104 | $9 |
Year by year
| 2024 | 447 | 185 | None | 3% | $8,772 |
| 2023 | 328 | 147 | 0% (0) | 5% | $10,172 |
| 2022 | 413 | 179 | 0% (0) | 9% | $14,455 |
| 2021 | 474 | 199 | 0% (0) | 9% | $22,066 |
| 2020 | 434 | 182 | 0% (0) | 13% | $20,218 |
| 2019 | 336 | 159 | None | 21% | $15,084 |
| 2018 | 372 | 166 | 0% (0) | 12% | $14,598 |
| 2017 | 501 | 172 | None | 10% | $25,773 |
| 2016 | 607 | 193 | 0% (0) | 15% | $33,287 |
| 2015 | 512 | 185 | 0% (0) | 18% | $29,668 |
| 2014 | 591 | 181 | None | 24% | $48,099 |
| 2013 | 571 | 158 | None | 26% | $37,011 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Ofloxacin | 28 | $1,868 | $67 |
| Fluticasone Propionate | 50 | $1,053 | $21 |
| Betamethasone Valerate | 15 | $482 | $32 |
| Azelastine | 21 | $331 | $16 |
| Famotidine | 31 | $326 | $11 |
| Acetic Acid | 14 | $280 | $20 |
| Omeprazole | 34 | $194 | $6 |
| Levocetirizine Dihydrochloride | 18 | $186 | $10 |
| Amoxicillin-Clavulanate Potass | 14 | $180 | $13 |
| Mupirocin | 21 | $151 | $7 |
2022: 14 drugs
| Ofloxacin | 38 | $2,579 | $68 |
| Betamethasone Valerate | 31 | $1,282 | $41 |
| Azelastine | 29 | $1,150 | $40 |
| Fluticasone Propionate | 51 | $1,004 | $20 |
| Clotrimazole | 12 | $729 | $61 |
| Famotidine | 31 | $587 | $19 |
| Omeprazole | 34 | $471 | $14 |
| Lansoprazole | 17 | $401 | $24 |
| Pantoprazole | 21 | $391 | $19 |
| Doxycycline Hyclate | 16 | $225 | $14 |
| Amoxicillin-Clavulanate Potass | 18 | $177 | $10 |
| Mupirocin | 22 | $144 | $7 |
| Montelukast | 16 | $133 | $8 |
| Levocetirizine Dihydrochloride | 16 | $129 | $8 |
2021: 13 drugs
| Ofloxacin | 75 | $6,200 | $83 |
| Ciprofloxacin-Dexamethasone | 17 | $3,396 | $200 |
| Fluticasone Propionate | 95 | $1,654 | $17 |
| Betamethasone Valerate | 25 | $790 | $32 |
| Famotidine | 22 | $663 | $30 |
| Azelastine | 22 | $562 | $26 |
| Amoxicillin-Clavulanate Potass | 30 | $560 | $19 |
| Omeprazole | 36 | $488 | $14 |
| Acetic Acid | 19 | $412 | $22 |
| Lansoprazole | 12 | $209 | $17 |
| Montelukast | 21 | $178 | $8 |
| Mupirocin | 28 | $161 | $6 |
| Pantoprazole | 11 | $149 | $14 |
2020: 11 drugs
| Ciprodex | 19 | $4,629 | $244 |
| Fluticasone Propionate | 105 | $1,704 | $16 |
| Ofloxacin | 33 | $1,418 | $43 |
| Clotrimazole | 15 | $620 | $41 |
| Famotidine | 23 | $601 | $26 |
| Omeprazole | 31 | $548 | $18 |
| Betamethasone Valerate | 28 | $469 | $17 |
| Acetic Acid | 17 | $412 | $24 |
| Amoxicillin-Clavulanate Potass | 23 | $411 | $18 |
| Mupirocin | 40 | $258 | $6 |
| Montelukast | 15 | $144 | $10 |
2019: 11 drugs
| Ciprodex | 34 | $7,994 | $235 |
| Fluticasone Propionate | 49 | $761 | $16 |
| Betamethasone Valerate | 27 | $508 | $19 |
| Doxycycline Hyclate | 13 | $423 | $33 |
| Omeprazole | 29 | $363 | $13 |
| Amoxicillin-Clavulanate Potass | 23 | $301 | $13 |
| Ranitidine | 13 | $257 | $20 |
| Levocetirizine Dihydrochloride | 14 | $178 | $13 |
| Mupirocin | 29 | $175 | $6 |
| Triamterene-Hydrochlorothiazid | 12 | $128 | $11 |
| Montelukast | 12 | $83 | $7 |
2018: 9 drugs
| Ciprodex | 24 | $5,332 | $222 |
| Fluticasone Propionate | 124 | $1,486 | $12 |
| Esomeprazole Magnesium | 14 | $1,351 | $96 |
| Omeprazole | 44 | $675 | $15 |
| Betamethasone Valerate | 16 | $321 | $20 |
| Ranitidine | 23 | $311 | $14 |
| Pantoprazole | 11 | $298 | $27 |
| Amoxicillin-Clavulanate Potass | 21 | $198 | $9 |
| Mupirocin | 19 | $186 | $10 |
2017: 12 drugs
| Esomeprazole Magnesium | 16 | $5,344 | $334 |
| Fluticasone Propionate | 172 | $2,556 | $15 |
| Azelastine | 18 | $1,216 | $68 |
| Ofloxacin | 18 | $671 | $37 |
| Omeprazole | 41 | $601 | $15 |
| Amoxicillin-Clavulanate Potass | 21 | $505 | $24 |
| Pantoprazole | 13 | $421 | $32 |
| Montelukast | 30 | $340 | $11 |
| Mupirocin | 24 | $264 | $11 |
| Betamethasone Valerate | 11 | $253 | $23 |
| Ranitidine | 31 | $251 | $8 |
| Levocetirizine Dihydrochloride | 15 | $173 | $12 |
2016: 12 drugs
| Nexium | 14 | $5,431 | $388 |
| Nasonex | 18 | $4,705 | $261 |
| Ciprodex | 22 | $4,239 | $193 |
| Fluticasone Propionate | 198 | $2,360 | $12 |
| Omeprazole | 72 | $957 | $13 |
| Montelukast | 41 | $640 | $16 |
| Ofloxacin | 15 | $565 | $38 |
| Pantoprazole | 29 | $499 | $17 |
| Betamethasone Valerate | 16 | $361 | $23 |
| Amoxicillin-Clavulanate Potass | 25 | $330 | $13 |
| Mupirocin | 28 | $266 | $9 |
| Ranitidine | 21 | $236 | $11 |
2015: 13 drugs
| Nexium | 19 | $8,226 | $433 |
| Ciprodex | 32 | $5,655 | $177 |
| Nasonex | 17 | $5,366 | $316 |
| Azelastine | 16 | $1,527 | $95 |
| Fluticasone Propionate | 105 | $1,392 | $13 |
| Omeprazole | 100 | $1,152 | $12 |
| Montelukast | 51 | $608 | $12 |
| Rabeprazole | 11 | $461 | $42 |
| Pantoprazole | 24 | $338 | $14 |
| Betamethasone Valerate | 11 | $308 | $28 |
| Mupirocin | 22 | $232 | $11 |
| Amoxicillin-Clavulanate Potass | 11 | $166 | $15 |
| Cephalexin | 12 | $51 | $4 |
2014: 10 drugs
| Nexium | 45 | $22,398 | $498 |
| Ciprodex | 35 | $5,531 | $158 |
| Nasonex | 14 | $3,296 | $235 |
| Omeprazole | 143 | $2,076 | $15 |
| Montelukast | 91 | $1,549 | $17 |
| Fluticasone Propionate | 68 | $1,350 | $20 |
| Triamcinolone Acetonide | 11 | $940 | $85 |
| Mupirocin | 33 | $374 | $11 |
| Pantoprazole | 28 | $314 | $11 |
| Amox Tr-Potassium Clavulanate | 18 | $252 | $14 |
2013: 10 drugs
| Nexium | 31 | $9,058 | $292 |
| Nasonex | 34 | $6,085 | $179 |
| Ciprodex | 23 | $3,458 | $150 |
| Omeprazole | 177 | $3,386 | $19 |
| Montelukast | 89 | $3,336 | $37 |
| Astepro | 13 | $1,896 | $146 |
| Pantoprazole | 50 | $1,319 | $26 |
| Fluticasone Propionate | 27 | $1,255 | $46 |
| Amox Tr-Potassium Clavulanate | 33 | $693 | $21 |
| Mupirocin | 17 | $229 | $13 |
Money from drug and device companies
$493 in 2025
| 2025 | 6 | 22 | None | $493 |
| 2024 | 5 | 10 | None | $229 |
| 2023 | 6 | 10 | None | $225 |
| 2022 | 1 | 1 | None | $22 |
| 2020 | 3 | 4 | None | $144 |
| 2019 | 6 | 12 | None | $243 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Nucala | $221 | 11 payments
|
| Novartis Pharmaceuticals | Rhapsido | $122 | 5 payments
|
| Takeda Pharmaceuticals U.S.A. | Cuvitru | $72 | 3 payments
|
| Ascendis Pharma Endocrinology | Yorvipath | $30 | 1 payment
|
| ARS Pharmaceuticals Operations | Neffy | $26 | 1 payment
|
| Inspire Medical Systems | Inspire | $22 | 1 payment
|
See all 22 published payments
| GlaxoSmithKline | Meals · 2025-12-08 | Nucala | $23 |
| GlaxoSmithKline | Meals · 2025-11-17 | Nucala | $32 |
| Novartis Pharmaceuticals | Meals · 2025-11-10 | Rhapsido | $15 |
| GlaxoSmithKline | Meals · 2025-10-27 | Nucala | $23 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-10-20 | Cuvitru | $25 |
| Novartis Pharmaceuticals | Meals · 2025-10-15 | Rhapsido | $20 |
| GlaxoSmithKline | Meals · 2025-08-18 | Nucala | $18 |
| Novartis Pharmaceuticals | Meals · 2025-08-11 | None | $20 |
| ARS Pharmaceuticals Operations | Meals · 2025-07-28 | Neffy | $26 |
| GlaxoSmithKline | Meals · 2025-07-15 | Nucala | $25 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-07-02 | Cuvitru | $23 |
| Novartis Pharmaceuticals | Meals · 2025-06-25 | None | $33 |
| Inspire Medical Systems | Meals · 2025-06-23 | Inspire | $22 |
| GlaxoSmithKline | Meals · 2025-06-16 | Nucala | $30 |
| Novartis Pharmaceuticals | Meals · 2025-05-09 | None | $34 |
| GlaxoSmithKline | Meals · 2025-05-05 | Nucala | $24 |
| GlaxoSmithKline | Meals · 2025-04-13 | Nucala | $16 |
| Ascendis Pharma Endocrinology | Meals · 2025-04-10 | Yorvipath | $30 |
| GlaxoSmithKline | Meals · 2025-03-20 | Nucala | $12 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-02-24 | Cuvitru | $24 |
| GlaxoSmithKline | Meals · 2025-01-21 | Nucala | $1 |
| GlaxoSmithKline | Meals · 2025-01-17 | Nucala | $18 |
See earlier years (2024, 2023, 2022, 2020, 2019)
2024: $229
| GlaxoSmithKline | Nucala | $79 | 4 payments
|
| Genzyme | Dupixent | $49 | 2 payments
|
| Inspire Medical Systems | Inspire | $42 | 2 payments
|
| Novartis Pharmaceuticals | Xolair | $32 | 1 payment
|
| Optinose US | Xhance | $27 | 1 payment
|
2023: $225
| GlaxoSmithKline | Nucala | $61 | 3 payments
|
| Inspire Medical Systems | Inspire | $59 | 2 payments
|
| Genzyme | Dupixent | $37 | 1 payment
|
| Optinose US | Xhance | $29 | 2 payments
|
| Merck Sharp & Dohme | None | $22 | 1 payment
|
| Amgen | Tezspire | $17 | 1 payment
|
2022: $22
| OptiNose US | Xhance | $22 | 1 payment
|
2020: $144
| Intersect ENT | Sinuva | $70 | 1 payment
|
| Aerin Medical | Vivaer | $51 | 2 payments
|
| Genzyme | Dupixent | $23 | 1 payment
|
2019: $243
| OptiNose US | Xhance | $121 | 7 payments
|
| Aerin Medical | Vivaer Rf Stylus | $35 | 1 payment
|
| Genzyme | Dupixent | $22 | 1 payment
|
| Intersect ENT | Propel | $22 | 1 payment
|
| Stryker | Entellus - Xpress Ent Dilation System | $21 | 1 payment
|
| GlaxoSmithKline | Nucala | $21 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 91.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1033192216
- Licence
- NY 236933
- Trained
- Wright State University Boonshoft School of Medicine, 2000 · 26 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Otolaryngology (207Y00000X); Federal specialty code 207YP0228X (207YP0228X)
- Mailing address
- 660 White Plains Rd Fl 4, Tarrytown, NY, 10591
- NPI first listed
- 2005-11-22
- NPI last updated
- 2025-07-22
- NPI record certified
- 2025-07-22
This is when the NPI record was last certified, not a medical board exam.